Prot #GS-US-361-1157: A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of GS 6615 on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy

Project: Research project

Project Details

StatusFinished
Effective start/end date7/25/147/25/20

Funding

  • PPD Development (GS-US-361-1157)
  • Gilead Sciences, Inc. (GS-US-361-1157)